FDA GIVES CONDITIONAL APPROVAL TO CANINE LYMPHOMA DRUG

被引：0
|
作者：
Cima, Greg
机构：
来源：
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2021年 / 258卷 / 05期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [21] Ruling gives FDA discretion in drug withdrawals
    Cima, Greg
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2014, 245 (06): : 623 - 623
  • [22] LONGTIME CANINE EPILEPSY TREATMENT GAINS CONDITIONAL APPROVAL
    Cima, Greg
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2021, 258 (05): : 444 - 445
  • [23] FDA shortened drug approval time in 1995
    不详
    PUBLIC HEALTH REPORTS, 1996, 111 (04) : 290 - 290
  • [24] 2004 Drug Approval Highlights FDA Update
    Laustsen, Gary
    Wimmett, Lynn
    NURSE PRACTITIONER, 2005, 30 (02): : 14 - 16
  • [25] FDA drug approval summaries:: Pemetrexed (Alimta®)
    Hazarika, M
    White, RM
    Johnson, JR
    Pazdur, R
    ONCOLOGIST, 2004, 9 (05): : 482 - 488
  • [26] FDA drug approval summary:: Panitumumab (Vectibix™)
    Giusti, Ruthann M.
    Shastri, Kaushikkumar A.
    Cohen, Martin H.
    Keegan, Patricia
    Pazdur, Richard
    ONCOLOGIST, 2007, 12 (05): : 577 - 583
  • [27] RECENT FDA DRUG APPROVAL - TRANEXAMIC ACID
    不详
    CLINICAL PEDIATRICS, 1987, 26 (12) : 668 - 668
  • [28] FDA NEW DRUG APPROVAL POLICY - WHY
    PATTERSON, R
    GRAMMER, LC
    NEW ENGLAND AND REGIONAL ALLERGY PROCEEDINGS, 1985, 6 (04): : 379 - 380
  • [29] The role of chemists in the FDA drug approval process
    Furness, M. Scott
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [30] FDA: Evidentiary Standards for Drug Development and Approval
    Katz R.
    NeuroRX, 2004, 1 (3): : 307 - 316
12345